Cesca Therapeutics Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Cesca Therapeutics Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Summary

Marketlines Cesca Therapeutics Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by Cesca Therapeutics Inc. since January2007.

Synopsis

Marketlines Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage.

Key Highlights

This report includes Cesca Therapeutics Inc.s contact information and business Summary, tables, graphs, a list of partners and targets, a breakdown of financial and legal advisors, deal types, top deals by deal value, detailed deal reports, and descriptions and contact details of the partner, target, investor, and vendor firms, where disclosed.

The profile also includes detailed deal reports for all M&A, private equity, public offering, venture financing, partnership and divestment transactions undertaken by Cesca Therapeutics Inc.. These deal reports contain information about target company financials, sources of financing, method of payment, deal values, and advisors for various parties, where disclosed.

Scope

- Provides intelligence on Cesca Therapeutics Inc.s M&A, strategic partnerships and alliances, capital raising and private equity transactions.
- Detailed reports of various financial transactions undertaken by Cesca Therapeutics Inc. and its subsidiaries since 2007.
- Information about key financial and legal advisors for Cesca Therapeutics Inc.s financial deals transactions.
- Financial deals tables and charts covering deal value and volumes trend, deal types and geography-based deal activity.

Reasons to buy

- Access comprehensive financial deals data along with charts and graph covering M&A, private equity, and partnerships and alliances.
- Form an independent opinion about Cesca Therapeutics Inc.s growth strategies through the organic and inorganic activities undertaken since 2007.
- Track your competitors business structure and growth strategies.


COMPANY OVERVIEW AND KEY FACTS
MERGERS & ACQUISITIONS
--Mergers and Acquisitions - Overview
--Mergers and Acquisitions - Deal reports
--Partnership - Deal reports
CAPITAL RAISING
--Capital Raising - Overview
--Capital Raising - Deal reports
--Divestments - Deal reports

APPENDIX
--About MarketLine Financial Deals Database
--Deal Definition and Methodology
--About MarketLine
--MarketLine Professional Services Knowledge Center

List Of Tables



--Cesca Therapeutics Inc. activity by deal type - volume (2013 -YTD2017)
--Cesca Therapeutics Inc. M&A average deal size - value ($m) (2013 -YTD2017)
--Cesca Therapeutics Inc. legal advisor ranking by value ($m)
--Cesca Therapeutics Inc. financial advisor ranking by value ($m)
--Top Deals(2013 -YTD2017)
--Cesca Therapeutics Inc. targets and partners (2013 -YTD2017)
--Cesca Therapeutics Inc. M&A volume and value trend (2013-YTD2017)
--Cesca Therapeutics Inc. M&A activity by geography (2013-YTD2017)
--Cesca Therapeutics Inc. capital raising volume and value trend (2013-YTD2017)
--Cesca Therapeutics Inc. capital raising by deal type (2013-YTD2017)

List Of Figures



--Cesca Therapeutics Inc. activity by deal type - volume (2013-YTD2017)
--Cesca Therapeutics Inc. M&A average deal size - value ($m)
--Cesca Therapeutics Inc. M&A volume and value trend (2013-YTD2017)
--Cesca Therapeutics Inc. M&A activity by geography (2013-YTD2017)
--Cesca Therapeutics Inc. capital raising volume and value trend (2013-YTD2017)
--Cesca Therapeutics Inc. capital raising by deal type (2013-YTD2017)

Cesca Therapeutics Inc (KOOL) - Product Pipeline Analysis, 2017 Update

Cesca Therapeutics Inc (Cesca) researches, develops, and commercializes cell based therapeutics for applications in regenerative medicine. Its proprietary technology platform, PXP is used to develop autologous cell-based therapies for the

USD 750 View Report

Cesca Therapeutics Inc (KOOL) - Financial and Strategic SWOT Analysis Review

Cesca Therapeutics Inc (KOOL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the companys businesses and operations. The profile has been compiled to

USD 125 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available